Skip to content
MARKETS / NASDAQ / EUDA
NASDAQ · SERVICES-HEALTH SERVICES · SMALL CAP

Euda Health Holdings Ltd. EUDA

5 fiscal years on record · USD · FY2025 reported · SEC filings only
$6.8M
▲ 70.0% YoY
$-2.8M
$-2.5M
In brief

What this company does

In January 2020, EUDA acquired 100% of the equity interests in Super Gateway Group Limited (“SGGL”), a property management service company that services shopping malls, business office building, or residential apartments. On November 17, 2022 (the “Closing Date”), the Company consummated the business combination contemplated by the Share Purchase Agreement (the “SPA”) between 8i Acquisition 2 Corp., a BVI business company (“8i”), EUDA Health Limited, a British Virgin Islands business company (“EHL”) EUDA Health’s strategy is anchored in wellness services (including the bioenergy cabins therapies and the stem cell therapies which have recently become available to EUDA for direct sales), designed to deliver accessible, holistic, and transformative care.

Written from the business description in EUDA Health Holdings Ltd's annual report to the U.S. Securities and Exchange Commission, filed 28 April 2026. Every sentence was checked against that document before publication.

Growth
USD 6.8M
Revenue, FY2025 · full 5-year series below
Revenue $M Net income $M
FY2025 · Revenue 6.8 · Net income -2.8
2.5M5.0M-10.0M-20.0M20212022202320242025
Compound annual growth
+21.9%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−41 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -36.3% · Net -40.6%
-200%-400%-600%20212022202320242025
ROE

Not applicable: equity was negative in this period, so return on equity has no meaning.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -2.5
0.2M0.4M-1.0M-2.0M20212022202320242025

Total assetsUSD 1.7M
EquityUSD -4.3M
CashUSD 345,144.00
Current ratio0.18×

Equity funds -248% of total assets.

The 5-year record
5 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021
Revenue $B0.00.00.00.00.0
Operating income $B−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.0−0.0
Income tax $B0.0−0.0·−0.00.0
Net income $B−0.0−0.0−0.0−0.00.0
Free cash flow $B−0.0−0.0·−0.00.0
EPS, diluted $−1.48−9.46−8.77−2.070.09
Dividend / sh $·····
Payout %·····
ROE %····165.9
Shares out B0.000.000.020.020.01

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 25 reconciliationsAUDITED

Reconciled in 5 of 19 fiscal years. 70 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Health Services
Listed onNASDAQ
Incorporated inoutside the United States — SEC code D8
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2021

Share this section

Download image